Dr. Mercola Interviews the Experts This article is part of a weekly series in which Dr. Mercola interviews various experts on a variety of health issues. To see more expert interviews, click here. As every year during our annual Fluoride Awareness Week, Fluoride Action Network (FAN) founder Dr. Paul Connett is here to provide us… Read More »
Women receiving tamoxifen for the treatment or prevention of breast cancer should be aware of possible drug-drug interactions between tamoxifen and specific antidepressant medications. Antidepressants are used widely to treat depression and anxiety disorders in midlife women. In addition, multiple studies have shown that SSRI and SNRI antidepressants are an effective non-hormonal treatment for hot… Read More »
Print this page NOVATO, Calif., and TOKYO, Sept. 30, 2019 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare diseases, and Kyowa Kirin Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for Crysvita (burosumab). The label has been updated to include… Read More »
[embedded content] KHN correspondent Rachel Bluth appeared on PBS Newshour Weekend to talk with host Megan Thompson about the continuing problem of surprise medical bills and how the issue is currently playing on Capitol Hill. Rachel’s interview begins around the 10 min. 55 second mark. For more information about medical bills, check out KHN’s Bill… Read More »